Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance

被引:268
作者
Park, Y
Harris, WS [1 ]
机构
[1] Univ Missouri, Dept Med, Kansas City, MO 64108 USA
[2] St Lukes Hosp, Lipid & Diabet Res Ctr, Kansas City, MO 64111 USA
关键词
eicosapentaenoic acid; docosahexaenoic acid; lipoprotein lipase;
D O I
10.1194/jlr.M200282-JLR200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Omega-3 fatty acids (FAs) reduce postprandial triacylglycerol (TG) concentrations. This study was undertaken to determine whether this effect was due to reduced production or increased clearance of chylomicrons. Healthy subjects (n = 33) began with a 4-week, olive oil placebo (4 g/d) run-in period. After a 4-week wash-out period, subjects were randomized to supplementation with 4 g/d of ethyl esters of either safflower oil (SAF), eicosapentaenoic acid (EPA), or docosahexaenoic acid (DHA) for 4 weeks. Results for EPA and DHA were similar, and therefore the data were combined into one omega-3 FA group. Omega-3 FA supplementation reduced the postprandial TG and apolipoprotein B (apo B)-48 and apoB-100 concentrations by 16% (P = 0.08), 28% (P < 0.001), and 24% (P < 0.01), respectively: Chylomicron TG half-lives in the fed state were reduced after w-3 FA treatment (6.0 +/- 0.5 vs. 5.1 +/- 0.4 min; P < 0.05), but not after SAF (6.9 +/- 0.7 vs. 7.1 +/- 0.7 min). Omega-3 FA supplementation decreased chylomicron particle sizes (mean diameter; 293 +/- 44 vs. 175 +/- 25 nm; P < 0.01) and increased pre-heparin lipoprotein lipase (LPL; 0.6 +/- 0.1 vs. 0.9 +/- 0.1 mumol/h/ml; P < 0.05) activity during the fed state, but had no effect on postheparin LPL or hepatic lipase activities.jlr The results suggest that omega-3 FA supplementation accelerates chylomicron TG clearance by increasing LPL activity, and that EPA and DHA are equally effective.
引用
收藏
页码:455 / 463
页数:9
相关论文
共 75 条
[21]   Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia [J].
Goodfellow, J ;
Bellamy, MF ;
Ramsey, MW ;
Jones, CJH ;
Lewis, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) :265-270
[22]   Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids [J].
Grimsgaard, S ;
Bonaa, KH ;
Hansen, JB ;
Nordoy, A .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 66 (03) :649-659
[23]  
GRUNDY SM, 1976, METABOLISM, V25, P1225, DOI 10.1016/S0026-0495(76)80006-6
[24]   Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia [J].
Hansen, JB ;
Grimsgaard, S ;
Nilsen, H ;
Nordoy, A ;
Bonaa, KH .
LIPIDS, 1998, 33 (02) :131-138
[25]  
HARRIS W S, 1991, Journal of Applied Nutrition, V43, P5
[26]  
HARRIS WS, 1990, J LIPID RES, V31, P1549
[27]   FISH OILS IN HYPERTRIGLYCERIDEMIA - A DOSE-RESPONSE STUDY [J].
HARRIS, WS ;
ROTHROCK, DW ;
FANNING, A ;
INKELES, SB ;
GOODNIGHT, SH ;
ILLINGWORTH, DR ;
CONNOR, WE .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1990, 51 (03) :399-406
[28]  
HARRIS WS, 1988, J LIPID RES, V29, P1451
[29]   Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases [J].
Harris, WS ;
Lu, GP ;
Rambjor, GS ;
Walen, AI ;
Ontko, JA ;
Cheng, Q ;
Windsor, SL .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 66 (02) :254-260
[30]  
Harris WS, 1997, J LIPID RES, V38, P503